glp 1 agonist alzheimer Frontiers Repurposing glucagon-like peptide-1 receptor agonists
Description
In theory, this avoids stomach upset and improves bioavailability

These tests use antibodies specific to particular drug classes, and there are no antibodies in standard panels designed to detect GLP-1 receptor agonists

[DOI] [PubMed] [Google Scholar] 926.Ambery P., Parker V.E., Stumvoll M., Posch M.G., Heise T., Plum-Moerschel L

10.1016/j.molmet.2021.101296 69 MetzlerM.Legendre-GuilleminV.GanL.ChopraV.KwokA.McPhersonP

When tested in pancreatectomised dogs the first fraction stimulated secretion from the pancreas while the second seemed to lower blood glucose without activating secretion from the pancreas

In the intervention arm the HbA1c at 6 months was on average 42.5 mmol/mol, whereas in placebo was 52.0 mmol/mol
